Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets
Hannah F. Bradford(The Royal Free Hospital), Claudia Mauri(The Royal Free Hospital), Liis Haljasmägi(University of Tartu), Darragh Duffy(Inserm), Rym Abida(University College London), Madhvi Menon(University of Manchester), Pärt Peterson(University of Tartu), David Isenberg(Regenerative Medicine Institute), Martti Vanker(University of Tartu), Vincent Bondet(Inserm), Kai Kisand(University of Tartu), Chris Wincup(King's College Hospital), Karita Särekannu(Institute of Clinical Research), Raquel Fernández González(University College London), Thomas McDonnell(University College London)
Cited by 48
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
|Annals of the Rheumatic Diseases|2012|1k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913